Valproate in Bipolar Disorder: Case Examples From a Family Practice

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Valproate is an antiepileptic drug with established efficacy in treating various nonepileptic disorders.
• It is an FDA-approved and generally well-tolerated medication for managing manic states in bipolar disorder.
• Emerging research indicates valproate's effectiveness in other bipolar spectrum illnesses.

Purpose of the Study:

• To present two clinical cases of DSM-IV bipolar disorder treated with valproate.
• To highlight the robust and sustained relief of mood symptoms achieved with valproate therapy.
• To review the clinical pharmacology of valproate in the context of bipolar disorder management.

Main Methods:

• Case report of two patients diagnosed with DSM-IV bipolar disorder.
• Valproate was administered as initial therapy in one case and as a replacement for lithium in another.
• Clinical outcomes and mood symptom response were monitored.

Main Results:

• Valproate provided robust and sustained relief of mood symptoms in both presented cases.
• In the first case, valproate effectively treated mixed hypomanic and depressive symptoms.
• In the second case, valproate offered an alternative for a patient with an incomplete response to lithium and antidepressant therapy.

Conclusions:

• Valproate is a valuable therapeutic option for managing bipolar disorder, including complex presentations.
• The drug demonstrates sustained efficacy in mood symptom control for bipolar patients.
• Clinical pharmacology of valproate supports its utility in a broader range of mood disorders.